HomeAI · summaries
Storia in 2 fonti
Exclusive: Treasury is assessing options to screen investments in China biotech
Treasury weighs adding biotech to outbound investment screening rules, a move that could chill or block US deals with China biotechs.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Exclusive: Treasury is assessing options to screen investments in China biotech
Treasury weighs adding biotech to outbound investment screening rules, a move that could chill or block US deals with China biotechs.
- ·
cryptobriefing.com
US Treasury assesses options to screen investments in China biotech
US lawmakers push Treasury to screen outbound biotech investments in China under the COINS Act. BINSA bill targets pharmaceutical IP and drug deals.